A stated preference survey to explore patient preferences for novel preventive migraine treatments - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36047857/
In this DCE assessing CGRP inhibitors attributes, the main driver of patient choice was treatment effectiveness, specifically reduced migraine severity, and consistent treatment effectiveness. Further, patients exhibited an overall preference for an oral tablet every other day over injectables. Pati ...
Conclusion: In this DCE assessing CGRP inhibitors attributes, the main driver of patient choice was treatment effectiveness, specifically reduced migraine severity, and consistent treatment effectiveness. Further, patients exhibited an overall preference for an oral tablet every other day over injectables. Patients' experience with previous treatments informs the value they place on treatment characteristics.
-
Huma Sheikh, CEO, NY Neurology Medicine, PCSeptember 28, 2022Very interesting.